Rationale and applications for macromolecular Gd‐based contrast agents

[1]  M. Moseley,et al.  Contrast-enhanced magnetic resonance imaging of tumor-bearing mice treated with human recombinant tumor necrosis factor alpha. , 1990, Cancer research.

[2]  M. Moseley,et al.  Evaluation of Gd-DTPA-labeled dextran as an intravascular MR contrast agent: imaging characteristics in normal rat tissues. , 1990, Radiology.

[3]  M E Moseley,et al.  Assessment of myocardial salvage after ischemia and reperfusion using magnetic resonance imaging and spectroscopy. , 1989, Circulation.

[4]  M. Moseley,et al.  Contrast-enhanced MRI of tumors. Comparison of Gd-DTPA and a macromolecular agent. , 1989, Investigative radiology.

[5]  M. Ogan,et al.  Albumin labeled with Gd-DTPA: an intravascular contrast-enhancing agent for magnetic resonance blood pool imaging: preparation and characterization. , 1987, Investigative radiology.

[6]  M E Moseley,et al.  Magnetic resonance imaging of myocardial infarction using albumin-(Gd-DTPA), a macromolecular blood-volume contrast agent in a rat model. , 1987, Investigative radiology.

[7]  M. Moseley,et al.  Comparison of Initial Biodistribution Patterns of Gd‐DTPA and Albumin‐(Gd‐DTPA) Using Rapid Spin Echo MR Imaging , 1987, Journal of computer assisted tomography.

[8]  U Schmiedl,et al.  Albumin labeled with Gd-DTPA as an intravascular, blood pool-enhancing agent for MR imaging: biodistribution and imaging studies. , 1987, Radiology.

[9]  R. Jain,et al.  Microvascular permeability of normal and neoplastic tissues. , 1986, Microvascular research.

[10]  R. Jain,et al.  Extravascular transport in normal and tumor tissues. , 1986, Critical reviews in oncology/hematology.

[11]  R. Ehman,et al.  Effect of gadolinium-DTPA on the magnetic relaxation times of normal and infarcted myocardium. , 1984, Radiology.

[12]  R. Ehman,et al.  Acute myocardial ischemia: magnetic resonance contrast enhancement with gadolinium-DTPA. , 1984, Radiology.

[13]  R. Brasch.  Work in progress: methods of contrast enhancement for NMR imaging and potential applications. A subject review. , 1983, Radiology.

[14]  G. Arturson,et al.  THE RENAL CLEARANCE OF DEXTRAN OF DIFFERENT MOLECULAR SIZES IN NORMAL HUMANS. , 1964, Scandinavian journal of clinical and laboratory investigation.

[15]  P. Owren.  A quantitative one-stage method for the assay of prothrombin. , 1949, Scandinavian journal of clinical and laboratory investigation.